AmirAli Talasaz is a co-founder and Co-CEO of Guardant Health, Inc., a company focused on precision oncology. With a Ph.D. in Bioengineering from Stanford University, Talasaz has deep expertise in biotechnology. He played key roles in developing genomic technologies during...
AmirAli Talasaz is a co-founder and Co-CEO of Guardant Health, Inc., a company focused on precision oncology. With a Ph.D. in Bioengineering from Stanford University, Talasaz has deep expertise in biotechnology. He played key roles in developing genomic technologies during his time at Illumina, where he also served as Senior Director of Diagnostics Research before launching Guardant Health in 2013. In August 2021, he transitioned to Co-CEO after previously being the President and COO. Interestingly, Talasaz has forgone his salary, opting for equity compensation instead, which shows his confidence in the company's future. Despite not receiving cash bonuses or equity awards since 2021 due to specific waivers, he has remained significantly involved in the company’s strategic direction and technical advancements. His focus is on improving cancer patients' journeys, emphasizing the importance of innovation in the company’s mission. Talasaz's leadership has been pivotal in aligning Guardant with market needs and responding to a rapidly evolving healthcare landscape.